Drugs / 000-0551
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01882647 | Jun 2013 → Mar 2014 | psoriasis | Therapeutics, Inc. | Completed | Met primary |
| Phase 3 | NCT01871402 | May → Dec 2013 | psoriasis | Therapeutics, Inc. | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 000-0551 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01871402 ↗ |
| Route | Topical | “Topical lotion, applied twice daily” NCT01871402 ↗ |